NCT06540066 2026-03-16
A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
BeOne Medicines
Phase 1 Terminated
BeOne Medicines
BeOne Medicines
BeOne Medicines
iTeos Therapeutics
Oncolytics Biotech
University of Utah